OpGen, Inc. Profile Avatar - Palmy Investing

OpGen, Inc.

OpGen, Inc., a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for t…

Medical - Diagnostics & Research
US, Rockville [HQ]

Lobbying Analysis

OpGen, Inc. has no lobbying expenses in our database.

History

Download
FY Quarter Expense For Lobby Disclosure LDA Reference
No data
End of OPGN's Analysis
CIK: 1293818 CUSIP: 68373L307 ISIN: US68373L4068 LEI: - UEI: -
Secondary Listings
OPGN has no secondary listings inside our databases.